Patent 7326682 was granted and assigned to Xenome Limited on February, 2008 by the United States Patent and Trademark Office.
The invention relates to an isolated, synthetic or recombinant χ-conotoxin peptide having the ability to inhibit a neuronal amine transporter, nucleic acid molecules encoding all or part of such peptides, antibodies to such peptides and uses and methods of treatment involving them.